Reveglucosidase alfa
Recombinant proteinexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
3
Phase 3
1
Phase 4
0
Earliest trial started Dec 1, 2010 (NCT01230801)
Timeline
Indications
Mechanism of action
- Lysosomal alpha-glucosidaseSupplementation
GAA supplementation
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL3707295 ↗
Also known as
- bmn 701
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01924845 | Phase 3 | Mar 1, 2014 | Biomarin |
| NCT01435772 | Phase 2 | Aug 1, 2011 | Biomarin |
| NCT01230801 | Phase 1/Phase 2 (Phase 2) | Dec 1, 2010 | Biomarin |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Biomarin | For profit | 3 | 3 | 2 | 2010 |
1 organizations
Page 1 / 1